Aarhus University Hospital,
Aarhus, 8000, Denmark
NCT Number: NCT01814280
Background:
Medication reviews performed on admission to hospitals reduce medication errors; however, evidence of effect on morbidity and mortality is currently inconsistent. It is known that patients' risks of experiencing medication errors are dependent on both patient- and drug factors, e.g. age, co-morbidity, number of drugs, risk of side effects.
Aim and hypothesis:
The aim of this pilot study is to study acute medical patients' risk of getting a medication error based on an algorithm that takes into account both patient and drug related factors. Secondary, the investigators will explore whether our methods are applicable in a randomised controlled trial. The investigators will also decide the number of patients in a randomised controlled trial based on this pilot study.
The hypothesis is that an algorithm that has already been developed can stratify patients according to their risk of experiencing a medication error.
Methods:
100 acute admitted patients will be risk stratified at admission (>8 hours after). The patients who have highest risks of medication errors will receive a medication review performed by either a clinical pharmacist or a clinical pharmacologist.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Aarhus, 8000, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Medication review performed by either a clinical pharmacist or a clinical pharmacologist
Time frame: During the patients' hospital stay
The patients' electronic medical record will be assessed for medication errors during the patients' hospitalization. It will be assesed by a clinical pharmacologist to assess the validity of the algorithm. Medication errors are defined as errors in prescriptions that either harm or have the potential to harm the patients.
University of Aarhus
Other
Differentiated Intervention Aimed at Reducing Medication Errors on Basis of an Individual Risk Assessment - a Pilot Study
Acronym: MERIS1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01722916
Drug Safety
Chicago, Illinois, United States
View Trial DetailsNCT06644105
Drug Metabolism, Drug Safety
Chengdu, China
View Trial DetailsNCT01669824
Aspirin, Drug Safety
Multiple Locations, Germany
View Trial DetailsNCT01367873
Drug Safety
Fargo, North Dakota, United States
View Trial Details